Caricamento...
Drug–drug interaction through molecular structure similarity analysis
BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/ https://ncbi.nlm.nih.gov/pubmed/22647690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|